Daptomicina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Daptomicina" in Italian language version.

refsWebsite

Global rank Italian rank

11doi.org

2^nd place

7^th place

4nih.gov

4^th place

9^th place

1asm.org

3,555^th place

2,382^nd place

1oxfordjournals.org

1,389^th place

732^nd place

1mja.com.au

low place

7,873^rd place

1worldcat.org

5^th place

26^th place

1oup.com

485^th place

613^th place

1oadoi.org

799^th place

22^nd place

1cubicin.com

low place

1web.archive.org

1^st place

asm.org

aac.asm.org

Woodworth JR, Nyhart EH, Brier GL, Wolny JD, Black HR, Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers, in Antimicrob Agents Chemother, vol. 36, n. 2, febbraio 1992, pp. 318–25, DOI:10.1128/AAC, PMID 1318678.

cubicin.com

Homepage del Cubicin Archiviato il 15 agosto 2006 in Internet Archive.

doi.org

dx.doi.org

Woodworth JR, Nyhart EH, Brier GL, Wolny JD, Black HR, Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers, in Antimicrob Agents Chemother, vol. 36, n. 2, febbraio 1992, pp. 318–25, DOI:10.1128/AAC, PMID 1318678.
Tally FP, DeBruin MF, Development of daptomycin for gram-positive infections, in J Antimicrob Chemother., vol. 46, n. 4, ottobre 2000, pp. 523–6, DOI:10.1093/jac/46.4.523, PMID 11020247.
Gilbert Habib, Patrizio Lancellotti e Manuel J. Antunes, 2015 ESC Guidelines for the management of infective endocarditis, in European Heart Journal, vol. 36, n. 44, 29 agosto 2015, pp. 3075–3128, DOI:10.1093/eurheartj/ehv319. URL consultato il 25 ottobre 2022.
(EN) Dennis L. Stevens, Alan L. Bisno e Henry F. Chambers, Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America, in Clinical Infectious Diseases, vol. 59, n. 2, 15 luglio 2014, pp. e10–e52, DOI:10.1093/cid/ciu296. URL consultato il 25 ottobre 2022.
Roberta Maria Antonello, Diana Canetti e Niccolò Riccardi, Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review, in Journal of Antimicrobial Chemotherapy, 13 ottobre 2022, DOI:10.1093/jac/dkac346. URL consultato il 25 ottobre 2022.
(EN) Sara Alosaimy, Noor L. Sabagha e Abdalhamid M. Lagnf, Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis, in Infectious Diseases and Therapy, vol. 9, n. 2, 1º giugno 2020, pp. 325–339, DOI:10.1007/s40121-020-00292-8. URL consultato il 25 ottobre 2022.
Sarah C J Jorgensen, Evan J Zasowski e Trang D Trinh, Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study, in Clinical Infectious Diseases, vol. 71, n. 1, 12 agosto 2019, pp. 1–10, DOI:10.1093/cid/ciz746. URL consultato il 25 ottobre 2022.
Fowler VG, Boucher HW, Corey GR, et al, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus, in N Engl J Med., vol. 355, n. 7, agosto 2006, pp. 653–65, DOI:10.1056/NEJMoa053783, PMID 16914701.

doi.org

Gilbert Habib, Patrizio Lancellotti e Manuel J. Antunes, 2015 ESC Guidelines for the management of infective endocarditis, in European Heart Journal, vol. 36, n. 44, 29 agosto 2015, pp. 3075–3128, DOI:10.1093/eurheartj/ehv319. URL consultato il 25 ottobre 2022.
(EN) Sara Alosaimy, Noor L. Sabagha e Abdalhamid M. Lagnf, Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis, in Infectious Diseases and Therapy, vol. 9, n. 2, 1º giugno 2020, pp. 325–339, DOI:10.1007/s40121-020-00292-8. URL consultato il 25 ottobre 2022.
Sarah C J Jorgensen, Evan J Zasowski e Trang D Trinh, Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study, in Clinical Infectious Diseases, vol. 71, n. 1, 12 agosto 2019, pp. 1–10, DOI:10.1093/cid/ciz746. URL consultato il 25 ottobre 2022.

mja.com.au

Charles PG, Grayson ML, The dearth of new antibiotic development: why we should be worried and what we can do about it, in Med J Aust., vol. 181, n. 10, novembre 2004, pp. 549–53, PMID 15540967.

nih.gov

ncbi.nlm.nih.gov

Woodworth JR, Nyhart EH, Brier GL, Wolny JD, Black HR, Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers, in Antimicrob Agents Chemother, vol. 36, n. 2, febbraio 1992, pp. 318–25, DOI:10.1128/AAC, PMID 1318678.
Tally FP, DeBruin MF, Development of daptomycin for gram-positive infections, in J Antimicrob Chemother., vol. 46, n. 4, ottobre 2000, pp. 523–6, DOI:10.1093/jac/46.4.523, PMID 11020247.
Charles PG, Grayson ML, The dearth of new antibiotic development: why we should be worried and what we can do about it, in Med J Aust., vol. 181, n. 10, novembre 2004, pp. 549–53, PMID 15540967.
Fowler VG, Boucher HW, Corey GR, et al, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus, in N Engl J Med., vol. 355, n. 7, agosto 2006, pp. 653–65, DOI:10.1056/NEJMoa053783, PMID 16914701.

oadoi.org

Fowler VG, Boucher HW, Corey GR, et al, Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus, in N Engl J Med., vol. 355, n. 7, agosto 2006, pp. 653–65, DOI:10.1056/NEJMoa053783, PMID 16914701.

oup.com

academic.oup.com

(EN) Dennis L. Stevens, Alan L. Bisno e Henry F. Chambers, Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America, in Clinical Infectious Diseases, vol. 59, n. 2, 15 luglio 2014, pp. e10–e52, DOI:10.1093/cid/ciu296. URL consultato il 25 ottobre 2022.

oxfordjournals.org

jac.oxfordjournals.org

Tally FP, DeBruin MF, Development of daptomycin for gram-positive infections, in J Antimicrob Chemother., vol. 46, n. 4, ottobre 2000, pp. 523–6, DOI:10.1093/jac/46.4.523, PMID 11020247.

web.archive.org

Homepage del Cubicin Archiviato il 15 agosto 2006 in Internet Archive.

worldcat.org

Rossi, Francesco, 1948- Riccardi, Carlo, 1949- Cuomo, Vincenzo, 1947- Berrino, Liberato, 1957., Farmacologia : principi di base e applicazioni terapeutiche, Minerva medica, 2020, ISBN 978-88-7711-995-7, OCLC 1146516753. URL consultato il 17 febbraio 2022.